Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 211 for “"Flt3"”.
-
Concomitant Inhibition of Flt3 and Mcl-1 In Flt3 Mutated Acute Myeloid Leukemia
The MCL-1 inhibitor S63845 synergizes with the FLT3 inhibitor midostaurin for potent anti-leukemic effect in preclinical human models of FLT3-ITD mutated acute myeloid leukemia (AML). Acute Myeloid leukemia (AML) is a neoplastic blood disorder defined by a characteristically rapid growth rate and …
-
Comparison of FLT3 inhibitors with the standard treatment for FLT3-ITD mutated acute myeloid leukemia
… a mutation in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 mutation most commonly occurs as an internal tandem duplication (ITD) and is associated with a poor prognosis. Patients with FLT3-ITD mutated AML are able to achieve complete remission at the same rate as patients with wild-type …
-
FLT3 INHIBITORS IN THE TREATMENT OF FLT3/ITD AML: OVERCOMING RESISTANCE AND DEFINING A THERAPEUTIC INDEX
… of the type III receptor tyrosine kinase (RTK) FLT3 occur in approximately 30% of acute myeloid leukemia (AML) patients and lead to constitutive activation. This has made FLT3 activating mutations an attractive drug target, as they are probable driver mutations of this disease. As more potent …
-
Molecular Mechanisms of FLT3-ITD-Induced Leukemogenesis
… in FMS-like receptor tyrosine kinase (FLT3-ITDs) are seen in approximately 25% of all acute myeloid leukemia (AML) patients. FLT3-ITDs induce FLT3 ligand (FL)-independent cellular hyperproliferation, promiscuous and aberrant activation of STAT5, and confer a poor prognosis in patients; …
-
The Role of the Bone Marrow Microenvironment in FLT3-ITD Acute Myeloid Leukemia Stem Cell Resistance to FLT3 Inhibition
… internal tandem duplications in the Flt3 receptor (Flt3-ITD) represent a distinct subtype of disease with poor prognosis, but unique opportunities for targeted therapy. Flt3-specific tyrosine kinase inhibitors (TKI) have entered clinical practice due to their ability to induce …
-
Mutationen des FLT3 Genes in akuter myeloider Leukaemie
… Mutationen in der juxtamembranösen Region (FLT3-Längenmutationen, FLT3-LM; FLT3- Interne Tandemduplikation, FLT3-ITD) und der Tyrosinkinase-Domäne (FLT3-TKD, FLT3-D835) von FLT3 stellen die häufigsten genetischen Alterationen in der AML dar und definieren eine …
-
FLT3-driven redox signalling in acute myeloid leukaemia
… common causative factors are mutations of the FLT3 gene, which codes for a growth factor receptor tyrosine kinase required by developing haematopoietic cells. Disruptions to this gene can result in constitutively active FLT3, driving the de-regulated proliferation of undifferentiated precursor …
-
Immunomodulation of Allergic Airway Inflammation by FLT3-ligand
… responses and/or increasing the Thl response. Flt3-ligand (Flt3-L) is a growth factor for dendritic cells, and induces type 1 T cell responses. The receptor for Flt3L is a member of the type 111 tyrosine kinase receptor family. A series of experiments were designed to examine the ability of …
-
Overcoming the Protective Effect of the Bone Marrow Microenvironment by Dual FLT3 and BET Inhibition in FLT3-ITD Acute Myeloid Leukemia
… mutations in the juxtamembrane region of the FLT3 receptor tyrosine kinase (FLT3-ITD) are found in about one-third of AML cases and confer a poor prognosis, particularly in relapsed or refractory settings. Although FLT3 tyrosine kinase inhibitors (TKIs) have been modestly successful as a …
-
FLT3-mutant leukemia: Signaling adaptation and novel mouse models
… including those in NPM1, CEBPA, RUNX1, and FLT3, have been shown to affect disease outcome. Among these mutations with prognostic significance, the internal tandem duplication in FLT3 (FLT3/ITD) is observed with the highest frequency in patients and confers poor prognosis. Given the …
-
Anti-leukemic activity of FLT3 ligand in murine leukemia
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
… mutations of Fms-like tyrosine kinase 3 (FLT3) are among the most frequent alterations in acute myeloid leukemia (AML). Two distinct types of mutations have been described: internal duplication of the juxtamembraneous domain (ITD) and point mutations of the tyrosine kinase domain (TKD). …
-
Ανίχνευση μεταλλάξεων του γονιδίου FLT3 στη οξεία μυελογενή λευχαιμία
… lead to this evolution are still not identified. FLT3 gene is located at 13q12 and encodes a transmembrane protein which functions as a receptor on the cell surface. FLT3 protein consists of 993 amino acids: an extracellular region (EC), a transmembrane domain (TM), a juxtamembrane domain, 2 …
-
DETERMINING THE MECHANISMS BEHIND ADAPTIVE RESISTANCE IN FLT3/ITD AML
… tyrosine kinase-3 internal tandem duplication (FLT3/ITD) mutation have a poorer prognosis. Targeted treatment with FLT3 tyrosine kinase inhibitors (TKI) have shown only limited success and have been hindered by mechanisms of resistance. One such resistance mechanism is known as adaptive …
-
Signal transduction through Flt3, a type III receptor tyrosine kinase
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
Aberrante Aktivierung der Rezeptortyrosinkinase FLT3 in der akuten myeloischen Leukämie
… Mutationen im ´FMS-like tyrosine kinase-3´ (FLT3)-Gen bekannt: FLT3-´internal tandem duplications´ (FLT3-ITD) in der juxtamembranösen (JM)-Domäne in 20 - 25 % der Patienten und FLT3-Punktmutationen in der Tyrosinkinasedomäne (FLT3-TKD) in 7 – 10 % der Patienten. In dieser Studie haben wir …
-
Regulation of flt3 gene expression in haematopoietic and leukaemic stem cells
… interaction between the tyrosine kinase receptor Flt3 and its ligand leads to signalling during the commitment of haematopoietic stem cells (HSCs). Constitutive activation of the Flt3/FL pathway is a key factor in enhanced survival and expansion in acute myeloid leukaemia (AML). Although there is …
-
Preclinical evaluation of CDK8 and FLT3 inhibitors for the treatment of cancer
… selective CDK8 inhibitor, and AU5-5, a potent FLT3 inhibitor, exploring their anti-cancer activity alone and in combination with standard chemotherapies and emerging agents such as venetoclax. The findings showed that AU2-85 can disrupt cell cycle regulation and enhance chemotherapy effects, …
Page 1 of 11